Lilly's diabetes drug as effective as Sanofi's in late-stage trials

Mon May 12, 2014 9:20am EDT

May 12 (Reuters) - Eli Lilly and Co said its type 2 diabetes treatment was as effective as Sanofi SA's approved drug Lantus in reducing patients' blood sugar levels in three late-stage trials.

Lilly said it expected to file for European and U.S. regulatory approval of the drug, called basal insulin peglispro, by the end of first quarter of 2015. (Reporting by Esha Dey in Bangalore; Editing by Savio D'Souza)

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.

A tourist takes a plunge as she swims at Ngapali Beach, a popular tourist site, in the Thandwe township of the Rakhine state, October 6, 2013. Picture taken October 6, 2013. REUTERS/Soe Zeya Tun (MYANMAR - Tags: SOCIETY) - RTR3FOI0

Where do you want to go?

We look at when to take trips, budget considerations and the popularity of multigenerational family travel.   Video